Meridiem Capital Partners LP Charles River Laboratories International, Inc. Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
A detailed history of Meridiem Capital Partners LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meridiem Capital Partners LP holds 120,034 shares of CRL stock, worth $21.6 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
120,034Holding current value
$21.6 Million% of portfolio
1.29%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
635Shares Held
52.8MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.05 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$916 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$678 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$392 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$335 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.16B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...